For example, high expression of the B-cell lymphoma (BCL)-6 and BCL-2 genes indicates that the prognosis of DLBCL is poor.[23] The immunohistochemistry results of patient 2 indicated positivity for BCL-2 and BCL-6, which implied that the prognosis was poor. This evidence concerns the gene BCL2 and diffuse large B-cell lymphoma.